Page 8 - Intercure Ltd News Today

InterCure Ltd (NASDAQ:INCR) is the largest cannabis company in Israel and the fastest- growing, most profitable marijuana company outside of North America. It reported record fourth-quarter and full-year 2021 results, and it expects that momentum to continue in 2022.

InterCure Estimates Record Fourth Quarter and Fiscal Year End 2021 Results(1) Fourth quarter 2021 Revenue and Adjusted EBITDA2 of $33 million and $9 million, representing an... #Canndoc #INCR #INCRU

04.04.2022 - Fourth quarter 2021 Revenue and Adjusted EBITDA2 of $33 million and $9 million, representing an increase of almost 200% and 140% YoY, respectively Record fiscal year 2021 revenue and Adjusted EBITDA2 of $89 million and $23 million, representing an ...

Will release financial results for the fourth quarter of 2021 before market open on Monday, April 4, 2022 Webcast scheduled for same day at 8:30am ET ...

Will release financial results for the fourth quarter of 2021 before market open on Monday, April 4, 2022Webcast scheduled for same day at 8:30am ET N

Leading global cannabis companies InterCure and Clever Leaves partner together to cultivate, market, and distribute pharmaceutical-grade medical cannabis in the EU, Australia and IsraelNEW YORK and... | March 22, 2022

InterCure Ltd. (NASDAQ:INCR) (TSX:INCR) (TASE: INCR) and Clever Leaves Holdings Inc. (NASDAQ:CLVR) (NASDAQ:CLVRW) have entered into an exclusive m...

Mr. Rabinovitch is one of the global cannabis senior executives to participate...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Press release content from Globe Newswire. The AP news staff was not involved in its creation.